Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
5.16
-0.07 (-1.34%)
At close: Oct 23, 2025, 4:00 PM EDT
5.16
0.00 (0.00%)
After-hours: Oct 23, 2025, 7:02 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2024.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,969,333
Market Cap
48.39M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TVRD News
- 8 days ago - TVRD SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - PRNewsWire
- 10 days ago - TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - Business Wire
- 10 days ago - Tvardi Therapeutics' Lung Disease Candidate Fails To Show Any Clinical Benefit, Stock Sinks - Benzinga
- 10 days ago - Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge - Benzinga
- 10 days ago - Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis - Business Wire
- 2 months ago - Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference - Business Wire
- 2 months ago - Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update - Business Wire
- 3 months ago - Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference - Business Wire